What is Autolus Therapeutics plc American Depositary Share's Enterprise Value?

Autolus Therapeutics plc American Depositary Share's Enterprise Value is $238.5M, based on as-reported figures from SEC (XBRL) filings.

What is Autolus Therapeutics plc American Depositary Share's Net Income (TTM)?

Autolus Therapeutics plc American Depositary Share's Net Income (TTM) is -$280.2M, based on as-reported figures from SEC (XBRL) filings.

What is Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM)?

Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.

What is Autolus Therapeutics plc American Depositary Share's EBITDA Margin?

Autolus Therapeutics plc American Depositary Share's EBITDA Margin is -203.5%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Autolus Therapeutics plc American Depositary Share

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00KVT06G6

1.54▼ 0.04 (-2.53%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 1.58
Day's Range: 1.50 – 1.58
52-Week Range: 1.18 – 2.58
Volume: 1.4M
Avg Volume: 1.6M

Share Statistics

Shares Outstanding
Employees: 752
Exchange: XNAS
Listed: 2018-06-22

Share count as of August 10, 2026

Autolus Therapeutics plc American Depositary Share (AUTL) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Autolus Therapeutics plc American Depositary Share (AUTL)

What is Autolus Therapeutics plc American Depositary Share's Market Cap?: Autolus Therapeutics plc American Depositary Share's Market Cap is $409.9M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Enterprise Value?: Autolus Therapeutics plc American Depositary Share's Enterprise Value is $238.5M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Price / Sales?: Autolus Therapeutics plc American Depositary Share's Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EV / Revenue?: Autolus Therapeutics plc American Depositary Share's EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EV / EBITDA?: Autolus Therapeutics plc American Depositary Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Revenue (TTM)?: Autolus Therapeutics plc American Depositary Share's Revenue (TTM) is $117.4M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Net Income (TTM)?: Autolus Therapeutics plc American Depositary Share's Net Income (TTM) is -$280.2M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EBITDA?: Autolus Therapeutics plc American Depositary Share's EBITDA is -$238.8M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM)?: Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EBITDA Margin?: Autolus Therapeutics plc American Depositary Share's EBITDA Margin is -203.5%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AUTLAs-filed SEC (XBRL) data